GAAP Financial Statements
Zomedica Corp. (ZOMDF)
3 quarters · 1 annual periods · CIK 0001684144
Quarterly (3)
| Period | Form | Revenue | Gross Profit | Op. Income | Net Income | EPS (Basic) | EPS (Dil.) | Assets | Cash |
|---|---|---|---|---|---|---|---|---|---|
| Q3 FY2025 | 10-Q | $8.1M | $5.4M | -$6.6M | -$6.1M | $-0.01 | $-0.01 | $130.9M | $7.5M |
| Q2 FY2025 | 10-Q | $1.4M | $4.7M | -$8.0M | -$7.4M | $-0.01 | $-0.01 | $136.5M | $8.1M |
| Q1 FY2025 | 10-Q | $4.5M | $4.4M | -$64.5M | -$63.8M | $-0.07 | $-0.07 | $143.0M | $4.5M |
Annual (1)
| Period | Form | Revenue | Gross Profit | Op. Income | Net Income | EPS (Basic) | EPS (Dil.) | Assets | Cash |
|---|---|---|---|---|---|---|---|---|---|
| FY FY2024 | 10-K | $27.3M | $226.0K | -$51.1M | -$47.0M | $-0.05 | $-0.05 | $207.4M | $7.0M |
Source: SEC EDGAR XBRL filings. Per-period figures are pulled from the original 10-Q / 10-K / 20-F submissions. Balance-sheet items (Assets, Cash, Equity) are point-in-time at period end.